In the report the epigenetics market, the market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2017-2025.
Get PDF Sample Brochure @ https://decisionmarketreports.com/request-sample?productID=1078182
The epigenetics market is driven by the driving factor such as declining prices of sequencing, and is likely to drive the market in the coming years. The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market.The market is likely to restrain its growth due to the factors such as high cost of advanced technologies. Companies such as Illumina and PacBio offer instruments with high cost. For instance, Illumina MiSeq cost for US$ 128,000 and PacBio RS cost for US$ 695,000. Thus, the high cost of next generation sequencers is hindering the growth of the market for in the future. Whereas the use of the neuroepigenetics to diagnose the neurodevelopmental disorders is likely to contribute a potential market growth in the forecast period.
The epigenetics market as per the product the segment is segmented as reagents, kits, enzymes, instruments and consumables and bioinformatics tools. The market of kits has the highest market share in 2017, contributing a market share of 29.8% and is expected to retain its dominance during the forecast period from 2018 to 2025. The epigenetic kits allows researchers to perform experiments, researchers to analyze epigenetic modifications efficiently and reliably by using antibodies directed against epitope tags or RNA-binding proteins. Thus holding the major market share. Likewise the reagents contributed 26.2% of the market share in the year 2017 and is expected to be the fastest growing market in the coming near future.
The technology segment of the epigenetics market includes histone modification, DNA methylation and other technologies. The DNA methylation segment for the epigenetics market was valued at US$ 506.29 Mn in 2017 and is estimated to grow at a CAGR of 13.9% during the forecast period from 2017 to 2025, to reach US$ 1,361.67.0 Mn by 2025. The DNA methylation segments is likely to dominate the market in the coming future as it supports the development of therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects. Thus the DNA methylation segment is expected to hold major share and is also the fastest growing segment during the forecast period.
Some of the major primary and secondary sources included in the report epigenetics market are National Institute of Environmental Health Sciences (NIEHS), Epidemiology and Genomics Research Program (EGRP), Canadian Institutes of Health Research (CIHR), Synthetic Biology Leadership Council, Chinese Academy of Sciences, World Health Organization, European Union, Food and Drug Administration and more.
TABLE OF CONTENTS
1. INTRODUCTION 22
1.1 SCOPE OF THE STUDY 22
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 22
2. GLOBAL EPIGENETICS MARKET – KEY TAKEAWAYS 24
3. GLOBAL EPIGENETICS MARKET – MARKET LANDSCAPE 27
3.1 OVERVIEW 27
3.2 MARKET SEGMENTATION 27
3.2.1 Global Epigenetics Market – By Product 28
3.2.2 Global Epigenetics Market – By Technology 28
3.2.3 Global Epigenetics Market – By Application 29
3.2.4 Global Epigenetics Market – By End User 29
3.2.5 Global Epigenetics Market – By Geography 29
4. GLOBAL EPIGENETICS MARKET – KEY MARKET DYNAMICS 30
4.1 KEY MARKET DRIVERS 30
4.1.1 Declining Prices of Sequencing 30
4.1.2 Increasing Prevalence of Cancer 30
4.1.3 Funds & Grants Provided By Government Bodies 30
4.2 KEY MARKET RESTRAINTS 31
4.2.1 High Cost of Advanced Technologies 31
4.2.2 Perception of the People For Genetic Alteration 31
4.3 KEY MARKET OPPORTUNITIES 32
4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine 32
4.3.2 Emerging Nations 32
4.4 KEY MARKET CHALLENGE 33
4.4.1 Lack of Skilled Professionals 33
4.5 FUTURE TRENDS 33
4.5.1 Promising Precise Treatments by Neurogenetics 33
4.6 IMPACT ANALYSIS 34
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.
304, S Jones Blvd,
NV 89107, USA
US Toll Free +18666051052
Email: [email protected]